课题基金 / 基金详情

Determination of the mechanism underlying Thorase modulation of AMPARs mediated neurotransmission

Determination of the mechanism underlying Thorase modulation of AMPARs mediated neurotransmission
确定 Thorase 调节 AMPAR 介导的神经传递的机制
批准号:
9755522
负责人:
George Kwabena Essien Umanah
金额:
$22.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-30 至 2020-08-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract My scientific training includes protein biochemistry during my doctorate and post-doctoral training in neuroscience. My long-term career goal is to become an independent investigator focusing on mechanisms of neurologic diseases related to the AAA+ ATPase Thorase. My goal over the next three years is to acquire additional knowledge and expertise in structural biology in order to elucidate how Thorase is structured and organized in oligomeric complexes to interact with α-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid receptors (AMPARs). With the help of a team of outstanding mentors, we have developed a structured training program that includes extensive hands-on research training in protein crystallization, negative staining, and single particle cryo-electron microscopy, as well as taking formal courses, presenting at seminars, attending scientific meetings, and training in grant writing. This training program will help me achieve the goals proposed in this K01 and ultimately prepare me to be in a position to compete for R01 funding. Thorase plays a critical role in controlling synaptic plasticity, learning, and memory by modulating the expression of surface AMPARs. Mutations in Thorase have been associated with schizophrenia and in some cases, neonates expressing loss-of-function Thorase demonstrate extreme hypertonia, encephalopathy, seizures, and early death. Mice with Thorase mutations have defects in glutamatergic signaling and deficits in behavior. The abnormalities linked to defects in Thorase function can be normalized by the AMPAR antagonist, perampanel, both in patients and mice. These findings suggest that Thorase could be an important mediator of neurologic diseases, such as schizophrenia, that are linked to compromised AMPAR-mediated glutamatergic neurotransmission. How Thorase modulates AMPAR- mediated glutamatergic neurotransmission remains to be elucidated. AAA+ ATPases are known to form oligomeric complexes that are critical for their functions. The structure of Thorase and the exact number of protomers present in its oligomeric complex are currently unknown. To probe these questions, my mentors and I have designed a series of studies that will provide vital information underlying the mechanism of Thorase-mediated AMPAR trafficking/recycling, as well as other Thorase functions in neurons. To attain these goals, the research aims of the proposal are to (i) determine the different oligomeric states of Thorase using single particle cryo-EM; (ii) identify specific residues of Thorase that are critical for AMPAR trafficking; (iii) determine the crystal structure of Thorase bound to the C-terminus of the AMPAR subunit GluA2 using x-ray crystallography; and (iv) identify new interacting protein partners of Thorase oligomeric complexes. Knowing the structure of Thorase and how its oligomeric complex interacts with AMPARs will advance our understanding of how Thorase mediates changes in synaptic plasticity via AMPAR signaling. This study may also identify new potential therapeutic targets for Thorase and AMPAR-mediated neurologic disease.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/s41380-021-01281-0
发表时间: 2021-12
期刊: Molecular psychiatry
影响因子: 11
作者: [Brant B, Stern T, Shekhidem HA, Mizrahi L, Rosh I, Stern Y, Ofer P, Asleh A, Umanah GKE, Jada R, Levy NS, Levy AP, Stern S]
通讯作者: Stern S
国内基金
海外基金
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
  • 批准号:
    22007039
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    王黎明
  • 依托单位:
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
  • 批准号:
    21172061
  • 项目类别:
    面上项目
  • 资助金额:
    30.0万元
  • 批准年份:
    2011
  • 负责人:
    许新华
  • 依托单位: